These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 7586898)

  • 1. Pharmacokinetic optimisation of antiretroviral therapy in patients with HIV infection.
    Stretcher BN
    Clin Pharmacokinet; 1995 Jul; 29(1):46-65. PubMed ID: 7586898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of nucleoside antiretroviral agents.
    Dudley MN
    J Infect Dis; 1995 Mar; 171 Suppl 2():S99-112. PubMed ID: 7861025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects.
    Cimoch PJ; Lavelle J; Pollard R; Griffy KG; Wong R; Tarnowski TL; Casserella S; Jung D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):227-34. PubMed ID: 9495222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiretroviral treatment in human immunodeficiency virus infection].
    Blum L; Bachmeyer C
    Ann Dermatol Venereol; 1997; 124(9):641-54. PubMed ID: 9739932
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antiretroviral therapy. Current status and perspectives].
    Lüthy R
    Internist (Berl); 1994 Oct; 35(10):896-900. PubMed ID: 8002223
    [No Abstract]   [Full Text] [Related]  

  • 6. An approach to antiretroviral treatment of HIV disease. Nucleoside monotherapy.
    Gunnarsson G; Hammer SM
    Hosp Pract (1995); 1995 Aug; 30 Suppl 1():5-22. PubMed ID: 7635917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of antiretroviral drug therapy in human immunodeficiency virus infection.
    Stretcher B
    Crit Rev Clin Lab Sci; 1994; 31(2):169-96. PubMed ID: 7917008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interactions with antiviral drugs.
    Taburet AM; Singlas E
    Clin Pharmacokinet; 1996 May; 30(5):385-401. PubMed ID: 8743337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current perspectives on antiretroviral therapy.
    Fletcher CV
    Pharmacotherapy; 1993; 13(6):627-33. PubMed ID: 7508101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Didanosine. An update on its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV disease.
    Perry CM; Balfour JA
    Drugs; 1996 Dec; 52(6):928-62. PubMed ID: 8957161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of nucleoside analogues on psychomotor slowing in HIV infection.
    Arendt G; von Giesen HJ; Hefter H; Theisen A
    AIDS; 2001 Mar; 15(4):493-500. PubMed ID: 11242146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of HIV infection: the antiretroviral nucleoside analogues. Introduction.
    McLeod GX; Hammer SM
    Hosp Pract (Off Ed); 1992 Aug; 27 Suppl 2():3-4. PubMed ID: 1324256
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of zidovudine, didanosine, zalcitabine and no antiretroviral therapy in patients with advanced HIV disease.
    Torres RA; Barr MR; McIntyre KI; Thornton JR; Shay WM; Feldman RD; George NJ; Britton DJ
    Int J STD AIDS; 1995; 6(1):19-26. PubMed ID: 7727578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stavudine: a review of its pharmacodynamic and pharmacokinetic properties and clinical potential in HIV infection.
    Lea AP; Faulds D
    Drugs; 1996 May; 51(5):846-64. PubMed ID: 8861550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HIV infection--current possibilities in antiviral therapy].
    Hirschel B
    Ther Umsch; 1994 Aug; 51(8):545-50. PubMed ID: 7940411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined drugs may be better than zidovudine alone for immunocompromised adults infected with HIV-1.
    Commun Dis Rep CDR Wkly; 1995 Oct; 5(42):209. PubMed ID: 7496435
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies of zidovudine in combination with didanosine and zalcitabine.
    Jablonowski H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiretroviral treatment against HIV].
    González-Lahoz J; Soriano V
    Med Clin (Barc); 1995 Sep; 105(10):377-8. PubMed ID: 7475441
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
    Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
    Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV therapy advances. Pediatric antiretroviral choices.
    Spector SA
    AIDS; 1994 Sep; 8 Suppl 3():S15-8. PubMed ID: 7840911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.